ULTRACET Drug Patent Profile

✉ Email this page to a colleague

When do Ultracet patents expire, and what generic alternatives are available?

Ultracet is a drug marketed by Janssen Pharms and is included in one NDA.

The generic ingredient in ULTRACET is acetaminophen; tramadol hydrochloride. There are sixty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the acetaminophen; tramadol hydrochloride profile page.

AI Research Assistant

Questions you can ask:

What is the 5 year forecast for ULTRACET?
What are the global sales for ULTRACET?
What is Average Wholesale Price for ULTRACET?

Summary for ULTRACET

US Patents:	0
Applicants:	1
NDAs:	1
Clinical Trials:	26
Drug Prices:	Drug price information for ULTRACET
What excipients (inactive ingredients) are in ULTRACET?	ULTRACET excipients list
DailyMed Link:	ULTRACET at DailyMed

Drug patent expirations by year for ULTRACET

Recent Clinical Trials for ULTRACET

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Pfizer	Phase 4
Gia Dinh People Hospital	N/A
The Catholic University of Korea	N/A

See all ULTRACET clinical trials

US Patents and Regulatory Information for ULTRACET

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Janssen Pharms	ULTRACET	acetaminophen; tramadol hydrochloride	TABLET;ORAL	021123-001	Aug 15, 2001		DISCN	Yes	No	⤷ Sign Up	⤷ Sign Up				⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for ULTRACET

Subscribe to access the full database, or Sign Up
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Janssen Pharms	ULTRACET	acetaminophen; tramadol hydrochloride	TABLET;ORAL	021123-001	Aug 15, 2001	⤷ Sign Up	⤷ Sign Up
Janssen Pharms	ULTRACET	acetaminophen; tramadol hydrochloride	TABLET;ORAL	021123-001	Aug 15, 2001	⤷ Sign Up	⤷ Sign Up
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for ULTRACET

See the table below for patents covering ULTRACET around the world.

Subscribe to access the full database, or Sign Up
Country	Patent Number	Title	Estimated Expiration
Japan	H06502869		⤷ Sign Up
Denmark	0566709		⤷ Sign Up
China	1086133		⤷ Sign Up
>Country	>Patent Number	>Title	>Estimated Expiration

Supplementary Protection Certificates for ULTRACET

Subscribe to access the full database, or Sign Up
Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
0566709	91079	Luxembourg	⤷ Sign Up	91079, EXPIRES: 20170903
0566709	C300152	Netherlands	⤷ Sign Up	PRODUCT NAME: TRAMADOLI HYDROCHLORIDUM EN PARACETAMOLUM; NAT. REGISTRATION NO/DATE: RVG 28113 20030115; FIRST REGISTRATION: 359 228-3 2002050405
0566709	SPC023/2008	Ireland	⤷ Sign Up	SPC023/2008: 20090921, EXPIRES: 20170404
>Patent Number	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration	>SPC Description

AI Research Assistant

Questions you can ask:

Summary for ULTRACET

Recent Clinical Trials for ULTRACET

Make Better Decisions: Try a trial or see plans & pricing